Martha Porado

Editor, Canadian Healthcare Network

Author Profile

Martha Porado is a Toronto-based award-winning reporter and editor specializing in healthcare, science, business and political journalism. She is the editor of the Canadian Healthcare Network, prior to which she was the managing editor of the Medical Post and Pharmacy Practice + Business.

Her previous roles include associate editor of Benefits Canada magazine, where she specialized in institutional investment news. Her byline can also be found in many other Canadian publications, including Advisor’s Edge, Investment Executive, the Canadian Investment Review, Canadian Insurance Top Broker, Canadian Grocer, Now Magazine and the now defunct Vice. Prior to focusing on print and digital publishing, she worked at BNN Bloomberg’s downtown Toronto newsroom as a broadcast associate and production coordinator for live news broadcasts. She fondly remembers screening call-in questions for its popular Market Call program.

When she is not editing copy on new clinical research or putting together tomorrow’s Doctor Daily newsletter, she can be found watering her ceiling-scraping houseplants, driving around with antique furniture peeking out of her hatchback, or bragging about how she’s definitely seen more movies than you have.

ARTICLES BY THIS AUTHOR

9/1/2026
Patient advocacy and the pain of a catch coming too late
A clinical pharmacist trying to make a difference when he sees elevated PSA levels—with some situations harder to tackle than others.

Martha Porado
9/1/2026
OpenAI faces 30 new lawsuits from witnesses to mass shooting in Tumbler Ridge, B.C.
The plaintiffs are also seeking ‘historic compensatory and punitive damages to penalize OpenAI for its reckless disregard for public safety,’ as well as measures to prevent future incidents.

Martha Porado
8/31/2026
Nearly 400 physicians interested in joining dual practice system: Alberta government
The model is set to allow doctors to offer private services while also working in the public system, starting with elective surgeries like hip and knee replacements.

Martha Porado
8/27/2026
The ‘great imitator’ is back with a vengeance in Canada: What clinicians need to know about the new face of syphilis
Often thought to be a thing of the past, syphilis is making a comeback in Canada with new presentations that should put clinicians on high alert.

Martha Porado
8/26/2026
200-plus pills found in three Ottawa parks, no illnesses or illicit drugs: police
Police say a preliminary analysis suggests the pills are over-the-counter and prescription medications.

Martha Porado
8/26/2026
The cost of neurophobia in Canadian medical training
We have mapped the stars, descended into the ocean depths, yet the human brain remains one of the greatest mysteries humans have encountered.

Martha Porado
8/25/2026
Dolly Parton never cut the line
All over the world, people are spitting venom and the drawbridges are going up. But, giving of oneself, one’s time, one’s talent is what we’re all supposed to be doing. And no one could be a better example than the Queen of Country, Dolly Parton.

Martha Porado
8/25/2026
Dolly Parton's philanthropic legacy includes a $1 million donation to COVID vaccine research
Dolly Parton—who passed this week at age 80 of cancer—didn’t think her philanthropy made her special. She thought it was just part of being human.

Martha Porado
8/22/2026
How we are engineering bacteria to eat cancer
Researchers are working to engineer bacteria that can kill cancerous tumours while reducing harm to healthy cells and tissue.

Martha Porado
8/20/2026
QUIZ: Do you understand ultra-processed foods?
When it comes to healthy diets, it’s not just about calories and nutrients anymore.

Martha Porado
8/20/2026
A refresher on diabetic foot care
Preventing lower limb amputation starts with screening, offloading and rapid access to a multidisciplinary team for wounds.

Martha Porado
8/19/2026
Can type 2 diabetes medications be used for people with type 1 diabetes?
Recently, I was approached by a colleague who had seen a patient with type 1 diabetes using a glucagon-like peptide-1 receptor agonist in combination with basal bolus insulin to manage their glucose levels.

Martha Porado